Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Xetra  >  Carl Zeiss Meditec AG    AFX   DE0005313704

CARL ZEISS MEDITEC AG

(AFX)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Valuation
Fiscal Period: September 2017 2018 2019 2020 2021 2022
Capitalization1 3 9506 4849 3559 794--
Entreprise Value (EV)1 3 6975 8148 6789 2379 1439 022
P/E ratio 28,1x51,4x58,4x78,2x61,0x50,0x
Yield 1,25%0,76%0,62%0,50%0,63%0,71%
Capitalization / Revenue 3,32x5,06x6,41x7,14x6,60x5,97x
EV / Revenue 3,11x4,54x5,95x6,73x6,16x5,50x
EV / EBITDA 18,0x25,5x27,3x39,9x30,3x26,6x
Price to Book 3,25x5,01x6,69x6,73x6,16x5,63x
Nbr of stocks (in thousands) 89 44189 44189 44189 441--
Reference price (EUR) 44,272,5105110110110
Last update 12/09/201712/07/201812/06/201910/23/202010/23/202010/23/2020
1 EUR in Million
Estimates
Income Statement Evolution
Annual Income Statement Data
Fiscal Period: September 2017 2018 2019 2020 2021 2022
Net sales1 1 1901 2811 4591 3721 4841 642
EBITDA1 205228318232301339
Operating profit (EBIT)1 178197235192239289
Operating Margin 15,0%15,3%16,1%14,0%16,1%17,6%
Pre-Tax Profit (EBT)1 189179230147224274
Net income1 134126160121165200
Net margin 11,3%9,87%10,9%8,80%11,1%12,2%
EPS2 1,571,411,791,401,802,19
Dividend per Share2 0,550,550,650,550,690,78
Last update 12/09/201712/07/201812/06/201910/29/202010/29/202010/23/2020
1 EUR in Million
2 EUR
Estimates
Balance Sheet Analysis
Fiscal Period: September 2017 2018 2019 2020 2021 2022
Net Debt1 ------
Net Cash position1 253670678556651771
Leverage (Debt / EBITDA) -1,24x-2,93x-2,13x-2,40x-2,16x-2,28x
Free Cash Flow1 24,1171237136156165
ROE (Net Profit / Equities) 13,4%10,1%11,9%8,85%11,3%12,8%
Shareholders' equity1 1 0071 2551 3461 3651 4541 565
ROA (Net Profit / Asset) 9,37%7,70%8,67%5,65%7,67%9,06%
Assets1 1 4351 6421 8422 1372 1522 204
Book Value Per Share2 13,614,515,616,317,819,5
Cash Flow per Share2 0,442,092,462,082,312,94
Capex1 13,716,520,338,939,740,9
Capex / Sales 1,15%1,29%1,39%2,84%2,68%2,49%
Last update 12/09/201712/07/201812/06/201910/23/202010/23/202010/23/2020
1 EUR in Million
2 EUR
Estimates
Finances - Leverage
Financial data source
© 2020 S&P Global Market Intelligence
Key data
Capitalization (EUR)
9 793 742 415
Capitalization (USD)
11 419 942 182
Net sales (EUR)
1 459 321 000
Net sales (USD)
1 705 931 656
Number of employees
3 335
Sales / Employee (EUR)
437 578
Sales / Employee (USD)
511 524
Free-Float
40,9%
Free-Float capitalization (EUR)
4 006 503 165
Free-Float capitalization (USD)
4 671 762 086
Avg. Exchange 20 sessions (EUR)
18 345 455
Avg. Exchange 20 sessions (USD)
21 445 653
Average Daily Capital Traded
0,19%
EPS & Dividend